IRB Barcelona logo

News

Highlighting IRB Barcelona's impact on society

Structural Bioinformatics and Network Biology News

Innovation
The biomedicine boom
Media mentions
A new strategy against the invisible enemy
Media mentions
A computational tool for mapping pathological mutations in the interactome
Media mentions
A computational resource improves the analysis of human tumours
Protein network for Alzheimer's disease (source: dSysMap, IRB Barcelona)
Innovation
A tool developed at IRB Barcelona to be used by the international consortium Pan-Cancer for the analysis of human tumours
Innovation
“We can help to predict the negative effects of drugs that have not yet been studied”
Scheme of the predictive model of chemical substances and their association with human diseases. The orange and green circles show adverse and therapeutic effects respectively. The size of the circles is proportional to the number of molecules that hold t
Innovation
Researchers design a model to predict the effects of chemical substances on health
Media mentions
The challenge of being faster than Alzheimer's
Patrick Aloy develops the project "SysPharmAD" on Alzheimer's Disease financed by the ERC (Copyright: IRB Barcelona)
Institutional
New angles on Alzheimer’s disease
Media mentions
Patrick Aloy: "Alzheimer's needs to be tackled from a global perspective"
Math4Life is a new programme to train biostatisticians
Institutional
IRB launches Maths4Life to train biostatisticians
Patrick Aloy (right) and Roberto Mosca performed together with Arnaud Ceol the bioinformatics analysis (Author: J. Cosialls)
Scientific
A step closer to putting together the vital puzzle of the bacteria Escherichia coli
MareNostrum supercomputer facility at BSC (Image rights: BSC)
Institutional
Three Severo Ochoa Centres of Excellence join efforts in computational biology
irbbarcelona
Media mentions
"SysPharmAD", a project to stop Alzheimer's disease
Patrick Aloy leads the Structural Bioinformatics and Network Biology laboratory (Battista/Minocri, IRB)
Institutional
IRB receives 1.3 M€ from the European Research Council for investigation into Alzheimer's disease
irbbarcelona
Scientific
A 6-million euro European project to study stem cell aging
irbbarcelona
Media mentions
Preventing the unwanted effects of drugs
irbbarcelona
Media mentions
Researchers explain the cause of 1162 side effects
Scientific
An IRB Barcelona study contributes to the understanding and prevention of the side effects caused by drugs
irbbarcelona
Media mentions
The interactions between proteins, in one clic
Interactome3D allows to structurally annotate entire pathways and provide molecular details useful for understanding the role of human disease mutations.
Scientific
IRB Barcelona develops the first public-access resource that provides 3D information at molecular level for 12,000 protein interactions
Institutional
An international competition reaffirms the potential of bioinformatics in the diagnosis of disease
Media mentions
Video-abstracts: a new tool to make science more attractive
Institutional
IRB Barcelona and the BSC renew and expand their joint research programme in order to further computational biology
irbbarcelona
Media mentions
Scientists identify protein interactions associated with Alzheimer
Representation of the functional groups between proteins in Alzheimer's disease.
Scientific
Scientists identify the largest network of protein interactions related to Alzheimer's disease
Representation of the "filters" used in the computational strategy developed by the researchers
Scientific
Discovering novel cellular roles of Aurora A
Francisco Barriga (left), Amelie Stein and Roland A. Pache will be attending the 60 Nobel Laureate Meeting at Lindau.
Institutional
Five young scientists at IRB Barcelona to attend the Nobel Laureate Meeting in Lindau, Germany
Institutional
Biobusiness in Chicago
Protein interaction maps of an organism allow researchers to identify the weak points on which to design drugs -or to select drugs already available-, which can be useful against it. Patrick Aloy draws up this kind of map for the AntiPathoGN project.
Institutional
Six million euros to slow down bacterial infections